Finding an effective medical treatment often requires a search by trial and error. Making this search more efficient by minimizing the number of unnecessary trials could lower both costs and patient suffering. We formalize this problem as learning a policy for finding a near-optimal treatment in a minimum number of trials using a causal inference framework. We give a model-based dynamic programming algorithm which learns from observational data while being robust to unmeasured confounding. To reduce time complexity, we suggest a greedy algorithm which bounds the near-optimality constraint. The methods are evaluated on synthetic and real-world healthcare data and compared to model-free reinforcement learning. We find that our methods compare favorably to the model-free baseline while offering a more transparent trade-off between search time and treatment efficacy.
Recent work has made important contributions in the development of causally-interpretable meta-analysis. These methods transport treatment effects estimated in a collection of randomized trials to a target population of interest. Ideally, estimates targeted toward a specific population are more interpretable and relevant to policy-makers and clinicians. However, between-study heterogeneity not arising from differences in the distribution of treatment effect modifiers can raise difficulties in synthesizing estimates across trials. The existence of such heterogeneity, including variations in tre…
Meta-analysis is commonly used to combine results from multiple clinical trials, but traditional meta-analysis methods do not refer explicitly to a population of individuals to whom the results apply and it is not clear how to use their results to assess a treatment's effect for a population of interest. We describe recently-introduced causally-interpretable meta-analysis methods and apply their treatment effect estimators to two individual-participant data sets. These estimators transport estimated treatment effects from studies in the meta-analysis to a specified target population using indi…
Causally interpretable meta-analysis combines information from a collection of randomized controlled trials to estimate treatment effects in a target population in which experimentation may not be possible but covariate information can be collected from a simple random sample. In such analyses, a key practical challenge is systematically missing data when some baseline covariates are not collected in all trials. Here, we provide identification results for potential (counterfactual) outcome means and average treatment effects in the target population when covariate data are systematically missi…
We present methods for causally interpretable meta-analyses that combine information from multiple randomized trials to estimate potential (counterfactual) outcome means and average treatment effects in a target population. We consider identifiability conditions, derive implications of the conditions for the law of the observed data, and obtain identification results for transporting causal inferences from a collection of independent randomized trials to a new target population in which experimental data may not be available. We propose an estimator for the potential (counterfactual) outcome m…
Does adding a theorem to a paper affect its chance of acceptance? Does labeling a post with the author's gender affect the post popularity? This paper develops a method to estimate such causal effects from observational text data, adjusting for confounding features of the text such as the subject or writing quality. We assume that the text suffices for causal adjustment but that, in practice, it is prohibitively high-dimensional. To address this challenge, we develop causally sufficient embeddings, low-dimensional document representations that preserve sufficient information for causal identif…
We take steps towards causally interpretable meta-analysis by describing methods for transporting causal inferences from a collection of randomized trials to a new target population, one-trial-at-a-time and pooling all trials. We discuss identifiability conditions for average treatment effects in the target population and provide identification results. We show that assuming inferences are transportable from all trials in the collection to the same target population has implications for the law underlying the observed data. We propose average treatment effect estimators that rely on different …
Solvay Business School（索尔维商学院）；Vrije Universiteit Brussel（布鲁塞尔自由大学）；Faculty of Economics and Business（经济与商业学院）；Katholieke Universiteit Leuven（鲁汶大学）
Causal classification models are adopted across a variety of operational business processes to predict the effect of a treatment on a categorical business outcome of interest depending on the process instance characteristics. This allows optimizing operational decision-making and selecting the optimal treatment to apply in each specific instance, with the aim of maximizing the positive outcome rate. While various powerful approaches have been presented in the literature for learning causal classification models, no formal framework has been elaborated for optimal decision-making based on the e…
Causal mediation analysis concerns the pathways through which a treatment affects an outcome. While most of the mediation literature focuses on settings with a single mediator, a flourishing line of research has examined settings involving multiple mediators, under which path-specific effects (PSEs) are often of interest. We consider estimation of PSEs when the treatment effect operates through K(\geq1) causally ordered, possibly multivariate mediators. In this setting, the PSEs for many causal paths are not nonparametrically identified, and we focus on a set of PSEs that are identified under …
A Versatile Causal Discovery Framework to Allow Causally-Related Hidden Variables
University of California San Diego（加州大学圣地亚哥分校）；Carnegie Mellon University（卡内基梅隆大学）；Mohamed bin Zayed University of Artificial Intelligence（穆罕默德·本·扎耶德人工智能大学）；KDDI Research（KDDI研究所）
Conditioning on some set of confounders that causally affect both treatment and outcome variables can be sufficient for eliminating bias introduced by all such confounders when estimating causal effect of the treatment on the outcome from observational data. It is done by including them in propensity score model in so-called potential outcome framework for causal inference whereas in causal graphical modeling framework usual conditioning on them is done. However in the former framework, it is confusing when modeler finds a variable that is non-causally associated with both the treatment and th…
Arizona State University（亚利桑那州立大学）；University of Virginia（弗吉尼亚大学）
Counterfactual evaluation of novel treatment assignment functions (e.g., advertising algorithms and recommender systems) is one of the most crucial causal inference problems for practitioners. Traditionally, randomized controlled trials (A/B tests) are performed to evaluate treatment assignment functions. However, such trials can be time-consuming, expensive, and even unethical in some cases. Therefore, offline counterfactual evaluation of treatment assignment functions becomes a pressing issue because a massive amount of observational data is available in today's big data era. Counterfactual …
Identification of treatment effects in the presence of unmeasured confounding is a persistent problem in the social, biological, and medical sciences. The problem of unmeasured confounding in settings with multiple treatments is most common in statistical genetics and bioinformatics settings, where researchers have developed many successful statistical strategies without engaging deeply with the causal aspects of the problem. Recently there have been a number of attempts to bridge the gap between these statistical approaches and causal inference, but these attempts have either been shown to be…
Statistical methods to evaluate the effectiveness of interventions are increasingly challenged by the inherent interconnectedness of units. Specifically, a recent flurry of methods research has addressed the problem of interference between observations, which arises when one observational unit's outcome depends not only on its treatment but also the treatment assigned to other units. We introduce the setting of bipartite causal inference with interference, which arises when 1) treatments are defined on observational units that are distinct from those at which outcomes are measured and 2) there…
Stanford University（斯坦福大学）；Hoover Institution（胡佛研究所）；Wharton School, University of Pennsylvania（宾夕法尼亚大学沃顿商学院）；Princeton University（普林斯顿大学）
The empirical practice of using factor models to adjust for shared, unobserved confounders, $\mathbf{Z}$, in observational settings with multiple treatments, $\mathbf{A}$, is widespread in fields including genetics, networks, medicine, and politics. Wang and Blei (2019, WB) formalizes these procedures and develops the "deconfounder," a causal inference method using factor models of $\mathbf{A}$ to estimate "substitute confounders," $\hat{\mathbf{Z}}$, then estimating treatment effects by regressing the outcome, $\mathbf{Y}$, on part of $\mathbf{A}$ while adjusting for $\hat{\mathbf{Z}}$. WB cl…
Stochastic Causal Programming for Bounding Treatment Effects
Helmholtz AI（亥姆霍兹人工智能研究所）；Helmholtz Munich（亥姆霍兹慕尼黑中心）；Technical University Munich（慕尼黑工业大学）；University College London（伦敦大学学院）；King’s College London（伦敦国王学院）
The optimal dynamic treatment rule (ODTR) framework offers an approach for understanding which kinds of patients respond best to specific treatments -- in other words, treatment effect heterogeneity. Recently, there has been a proliferation of methods for estimating the ODTR. One such method is an extension of the SuperLearner algorithm -- an ensemble method to optimally combine candidate algorithms extensively used in prediction problems -- to ODTRs. Following the "causal roadmap," we causally and statistically define the ODTR and provide an introduction to estimating it using the ODTR SuperL…
Amazon（亚马逊）；Massachusetts Institute of Technology（麻省理工学院）
We extend the definition of the marginal causal effect to the continuous treatment setting and develop a novel characterization of causal bias in the framework of structural causal models. We prove that our derived bias expression is zero if, and only if, the causal effect is identifiable via covariate adjustment. We show that under some restrictions on the structural equations, the causal bias can be estimated efficiently and allows for causal regularization of predictive probabilistic models. We demonstrate the effectiveness of our method for causal bias quantification in various settings wh…
Efficient Adaptive Experimental Design for Average Treatment Effect Estimation
The University of Tokyo（东京大学）；Mizuho-DL Financial Technology Co., Ltd.（瑞穗数字金融科技有限公司）；Tohoku University（东北大学）；Kyoto University（京都大学）；Yale University（耶鲁大学）
本文提出一种面向 ATE 估计的自适应实验设计，通过估计高效处理分配概率并结合 A2IPW 估计量达到半参数效率界，且支持任意时刻有效的置信区间与最优序贯检验。
University of California, Berkeley（加州大学伯克利分校）；Twitter（推特）；Max Planck Institute for Intelligent Systems（马克斯·普朗克智能系统研究所）
Online platforms regularly conduct randomized experiments to understand how changes to the platform causally affect various outcomes of interest. However, experimentation on online platforms has been criticized for having, among other issues, a lack of meaningful oversight and user consent. As platforms give users greater agency, it becomes possible to conduct observational studies in which users self-select into the treatment of interest as an alternative to experiments in which the platform controls whether the user receives treatment or not. In this paper, we conduct four large-scale within…
Parameter Estimation using Reinforcement Learning Causal Curiosity: Limits and Challenges
Digital Scholarship at Oxford（牛津大学数字人文中心）；University of Oxford（牛津大学）；Faculty of Engineering and Applied Sciences（工程与应用科学学院）；Cranfield University（克兰菲尔德大学）
The same intervention can produce different effects in different sites. Transport mediation estimators can estimate the extent to which such differences can be explained by differences in compositional factors and the mechanisms by which mediating or intermediate variables are produced; however, they are limited to consider a single, binary mediator. We propose novel nonparametric estimators of transported stochastic (in)direct effects that consider multiple, high-dimensional mediators and intermediate variables. They are multiply robust, efficient, asymptotically normal, and can incorporate d…
With medical tests becoming increasingly available, concerns about over-testing and over-treatment dramatically increase. Hence, it is important to understand the influence of testing on treatment selection in general practice. Most statistical methods focus on average effects of testing on treatment decisions. However, this may be ill-advised, particularly for patient subgroups that tend not to benefit from such tests. Furthermore, missing data are common, representing large and often unaddressed threats to the validity of statistical methods. Finally, it is desirable to conduct analyses that…
Since the average treatment effect (ATE) measures the change in social welfare, even if positive, there is a risk of negative effect on, say, some 10% of the population. Assessing such risk is difficult, however, because any one individual treatment effect (ITE) is never observed, so the 10% worst-affected cannot be identified, while distributional treatment effects only compare the first deciles within each treatment group, which does not correspond to any 10%-subpopulation. In this paper we consider how to nonetheless assess this important risk measure, formalized as the conditional value at…
Tech companies (e.g., Google or Facebook) often use randomized online experiments and/or A/B testing primarily based on the average treatment effects to compare their new product with an old one. However, it is also critically important to detect qualitative treatment effects such that the new one may significantly outperform the existing one only under some specific circumstances. The aim of this paper is to develop a powerful testing procedure to efficiently detect such qualitative treatment effects. We propose a scalable online updating algorithm to implement our test procedure. It has thre…
We developed a study design for rare disease clinical trials (RDTs) that efficiently evaluate treatments, promotes access to new treatments during treatment development, and optimizes healthcare resource utilization for future treatment allocation, development, and prioritization. Comprehensive literature review and focus group discussion were conducted. To address the multifaceted challenges facing RDTs, four key issues for RDTs must be addressed, which are 1) the opportunity to access the new treatment; 2) assessment of outcomes where clinically validated outcomes may be lacking; 3) patient …
In biomedical science, analyzing treatment effect heterogeneity plays an essential role in assisting personalized medicine. The main goals of analyzing treatment effect heterogeneity include estimating treatment effects in clinically relevant subgroups and predicting whether a patient subpopulation might benefit from a particular treatment. Conventional approaches often evaluate the subgroup treatment effects via parametric modeling and can thus be susceptible to model mis-specifications. In this manuscript, we take a model-free semiparametric perspective and aim to efficiently evaluate the he…
Finding an optimal individualized treatment regimen is considered one of the most challenging precision medicine problems. Various patient characteristics influence the response to the treatment, and hence, there is no one-size-fits-all regimen. Moreover, the administration of an unsafe dose during the treatment can have adverse effects on health. Therefore, a treatment model must ensure patient \emph{safety} while \emph{efficiently} optimizing the course of therapy. We study a prevalent medical problem where the treatment aims to keep a physiological variable in a safe range and preferably cl…
